Update your location to show providers, locations, and services closest to you.
Pediatric Hematologist/Oncologist (Child Cancer Specialist)
John Fort, M.D., attended the University of Louisville for medical school and his pediatric residency. He then completed his fellowship in pediatric hematology/oncology at the University of Florida. Dr. Fort served as an assistant professor at George Washington University and an attending physician at Miami Children’s Hospital before joining the University of Florida faculty in 2012. He is a member of the American Society of Bone Marrow Transplantation, American Society of Pediatric Hematology/Oncology, Children’s Oncology Group, Pediatric Blood and Marrow Transplant Consortium and National Marrow Donor Program.
This is a Phase II, single arm, multi-center trial, designed to estimate the efficacy and toxicity of haploidentical bone marrow transplantation (BMT) in patients with sickle cell disease (SCD). Based on their age and entry criteria patients are…
The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants ages 6 months to
This is an investigator initiated, multicenter, open label, randomized phase 3 study for subjects with newly diagnosed ITP from ages 1 to less than 18 years old.
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
Ann Collett used to dread 7:30 p.m. At a time when many mothers across Gainesville were putting their young children to bed, Ann was preparing her son’s…
